Sheaff Brock Investment Advisors LLC Sells 95 Shares of Zoetis Inc. (NYSE:ZTS)

Sheaff Brock Investment Advisors LLC lessened its stake in Zoetis Inc. (NYSE:ZTS) by 2.9% in the third quarter, HoldingsChannel reports. The firm owned 3,180 shares of the company’s stock after selling 95 shares during the period. Sheaff Brock Investment Advisors LLC’s holdings in Zoetis were worth $621,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in ZTS. Dorsey & Whitney Trust CO LLC grew its stake in Zoetis by 16.0% in the first quarter. Dorsey & Whitney Trust CO LLC now owns 4,643 shares of the company’s stock valued at $786,000 after acquiring an additional 641 shares during the period. Nwam LLC grew its stake in Zoetis by 16.0% in the first quarter. Nwam LLC now owns 4,962 shares of the company’s stock valued at $836,000 after acquiring an additional 684 shares during the period. M&G Plc acquired a new position in Zoetis in the first quarter valued at about $19,819,000. Intech Investment Management LLC grew its stake in Zoetis by 94.6% in the first quarter. Intech Investment Management LLC now owns 2,320 shares of the company’s stock valued at $393,000 after acquiring an additional 1,128 shares during the period. Finally, Vanguard Group Inc. grew its stake in Zoetis by 1.0% in the first quarter. Vanguard Group Inc. now owns 40,749,571 shares of the company’s stock valued at $6,895,235,000 after acquiring an additional 414,605 shares during the period. 92.80% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have recently weighed in on ZTS. Argus raised Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. BTIG Research upped their price objective on Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research report on Monday, August 12th. Stifel Nicolaus upped their target price on Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a report on Wednesday, September 18th. Piper Sandler upped their target price on Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a report on Wednesday, August 14th. Finally, JPMorgan Chase & Co. upped their target price on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Ten analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, Zoetis presently has a consensus rating of “Buy” and an average target price of $221.44.

Zoetis Trading Up 0.3 %

NYSE ZTS opened at $175.12 on Friday. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. Zoetis Inc. has a twelve month low of $144.80 and a twelve month high of $201.92. The company has a market cap of $79.01 billion, a price-to-earnings ratio of 32.92, a price-to-earnings-growth ratio of 2.68 and a beta of 0.90. The business’s fifty day moving average is $187.09 and its 200 day moving average is $180.08.

Zoetis (NYSE:ZTS) last announced its earnings results on Monday, November 4th. The company reported $1.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.46 by $0.12. The business had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. Zoetis’s revenue for the quarter was up 11.6% compared to the same quarter last year. During the same period last year, the company earned $1.36 EPS. As a group, sell-side analysts expect that Zoetis Inc. will post 5.9 EPS for the current fiscal year.

Zoetis Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be given a dividend of $0.432 per share. This represents a $1.73 annualized dividend and a yield of 0.99%. The ex-dividend date is Thursday, October 31st. Zoetis’s dividend payout ratio is currently 32.52%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.